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RESIDUAL COGNITIVE IMPAIRMENTS IN REMITTED
DEPRESSED PATIENTS
Wendelien Merens, M.A.,1 Linda Booij, Ph.D.,1,2 and A. J. Willem Van Der Does, Ph.D.1,3
Depressive disorders are associated with various cognitive impairments. Studies
on whether or not these impairments persist into the euthymic phase have shown
conflicting results, due to differences in test versions and in study samples. In
this paper, we aimed to compare the cognitive performance of remitted depressed
patients with that of age- and gender-matched healthy volunteers across a wide
range of cognitive domains. In two studies, we found few differences on neutral
as well as emotional information processing tests. The findings indicate that
remitted depressed patients who use antidepressant medication still show an
increased recognition of facial expression of fear compared to healthy controls.
Patients also performed worse on a test of recognition of abstract visual
information from long-term memory. No other residual cognitive impairments
were found. These results indicate that most of the cognitive impairments
associated with depression resolve with recovery through medication, even when
recovery is incomplete. Considering the finding that remitted depressed patients
have higher levels of cognitive reactivity, future studies may investigate the
possibility that these cognitive impairments have not resolved but have become
latent, and may therefore easily be triggered by small changes in mood state.
Depression and Anxiety 25:E27–E36, 2008. & 2008 Wiley-Liss, Inc.
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INTRODUCTION
Problems concentrating and making decisions are
part of the diagnostic criteria of major depressive
disorder [MDD; American Psychiatric Association,
1994]. Experimental research has shown that memory,
learning, attention, motor function and problem
solving may also be affected in depressed patients
[Austin et al., 2001; Elliott, 1998; Weiland-Fiedler
et al., 2004]. The cognitive functions that are most
impaired in depression are those which require
effortful executive functioning, which is highly depen-
dent on the prefrontal cortex [Elliott, 1998]. Some
studies have focused on impairments in emotional (as
opposed to neutral) information processing in
depressed patients. For example, the recognition of
facial expressions of emotions has been found to be
affected in depressed patients [Bouhuys et al., 1999;
Gur et al., 1992]. Also an increased attentional bias for
negative information [Williams et al., 1996] and an
increased level of dysfunctional attitudes [Ingram et al.,
1998] are found compared to healthy controls.
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Given the high risk of relapse in depression, it is
important to investigate whether cognitive impair-
ments persist into the euthymic phase and if so,
whether these impairments may be predictive of
depressive relapse. Research on cognitive impairments
in recovered depressed patients has shown conflicting
results. These conflicting results may be a function of
differences in study sample, such as gender distribu-
tion, age, education level, residual depressive symp-
toms, medication status, and diagnosis. Marcos et al.
[1994] found differences on tests measuring paired
learning, immediate and delayed visual memory,
delayed logical memory, and block design between
euthymic patients and healthy controls. Part of the
patient sample was medicated with imipramine, part of
the sample was unmedicated at the time of study. The
two groups consisted of both men and women and were
equal in age (mean age 54 and 52 years, respectively)
and education level. In another study, differences
between depressed and nondepressed subjects on
different memory tests (verbal memory, immediate
and delayed recall, learning, retrieval) disappeared
following imipramine treatment, but only in treatment
responders. Improvement in depressive symptoms led
to significant improvement in memory performance
[Peselow et al., 1991]. Again both groups were equal in
age (mean 48–50 years), gender distribution (both men
and women were tested) and level of intelligence.
Paradiso et al. [1997] compared cognitive performance
of patients with a—relatively chronic—history of
unipolar and bipolar depressive disorder to that of
age (mean age 50–57 years) and education matched
controls. Only male subjects were included and almost
all patients were taking some form of psychotropic
medication (benzodiazepines, tricyclics, trazodone).
They found that euthymic unipolar patients performed
worse on tasks measuring executive function (Trail
Making B, Stroop CWT), visual-motor sequencing
(Trail Making A), immediate memory (word-list
memory test) and attention (digit symbols) compared
to healthy controls. In another study, unmedicated
male and female remitted depressed patients were
impaired on tasks of rapid visual information proces-
sing (sustained attention), psychomotor speed, and
spatial working memory compared to healthy controls
[Weiland-Fiedler et al., 2004]. However, after correct-
ing for residual depressive symptoms, only the differ-
ence in sustained attention remained significant. In this
study, mean ages were 36 and 38 years and all patients
had been taking antidepressant medication in the past.
These results were supported by another study that
found medicated and unmedicated euthymic patients to
be impaired in attentional and executive function
[Paelecke-Habermann et al., 2005].
Regarding emotional information processing,
persisting impairments have been found in the speci-
ficity of autobiographical memory [Spinhoven et al.,
2006], the recognition of facial emotions [Bouhuys
et al., 1999], and attentional bias [Williams et al.,
1996]. Some of these impairments are also related to
risk of relapse [Bouhuys et al., 1999; Williams et al.,
1996].
Overall, depressed patients show cognitive impair-
ments across a wide range of domains. Some of these
impairments improve with clinical recovery, whereas
others may persist into the euthymic phase. Some
cognitive impairments may even be related to depres-
sive relapse. However, following the results of
Weiland-Fiedler et al. [2004], it remains questionable
whether remitted depressed patients show any cogni-
tive impairments in comparison to an adequately
matched control group and, most importantly, when
residual depressive symptoms are taken into account.
This study investigated cognitive performance in
medicated, remitted depressed patients, who are
expected to show relatively high levels of residual
depressive symptoms, and two matched control groups.
To cover a wide range of tests, two separate studies
were undertaken. The two studies differed in the type
of information processing that was assessed. Study 1
included mainly tests of emotional information proces-
sing; study 2 included tests that assessed neutral
information processing. To check for possible differ-
ences between the study samples, both studies included
a fluency test and a measure of attentional bias. No
precise hypotheses were formed because the literature
does not provide unequivocal results.
MATERIALS AND METHODS
STUDY 1
Participants
Patients. As part of a larger study, two samples of
remitted depressed patients were recruited from a
Mood Disorders Program. Participants were male and
female outpatients (of the Mood Disorders Program of
Parnassia Psycho-medical Center, The Hague). Pa-
tients were at different stages in treatment, but were
referred to the study only when their therapist thought
they would meet criteria for remitted or recovered
depression. Age limit was 18–65 years. Participants had
to fulfill the following inclusion criteria: primary intake
diagnosis of DSM-IV MDD; no longer fulfilling DSM-
IV criteria for depression, and Hamilton-17 scores
lower than or equal to 15 [Frank et al., 1991]; ongoing
treatment with a selective serotonin reuptake inhibitor
(SSRI) or selective serotonin and noradrenalin reuptake
inhibitor (SSNRI) for at least 4 weeks; no history or
current psychotic disorder; no substance abuse in the
past 3 months, based on DSM-IV criteria; BMI equal
or higher than 18; free of neuro-endocrine
or neurological disease; no pregnancy or lactation
(females).1
1The patients in study 1 are the same sample as in Merens et al. (in
press); those in study 2 are the same as in Booij et al., 2005. J
Psychopharm 19:267–275. The present data are slightly different,
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Controls. Healthy control participants were
recruited through advertisements in local newspapers.
Participants were matched to the patient group on age
and gender. Inclusion criteria were: no mood disorders
(lifetime); no first degree relatives with a mood
disorder (lifetime); no history or current psychotic
disorder; no substance abuse in the past 3 months,
based on DSM-IV criteria; no use of psychotropic
medication, free of neuro-endocrine or neurological
disease.
Materials
Self-report. The Beck Depression Inventory [BDI;
Beck et al., 1996] is a self-rating scale that assesses the
presence and severity of depressive symptoms. The
Dutch version was used [BDI-II-NL; Van der Does,
2002b]. The Dysfunctional Attitudes Scale [DAS;
Weissman, 1979] assesses the level of dysfunctional
attitudes. A 22-item version was used, based on the
original form A. The Leiden Index of Depression
Sensitivity [LEIDS; Van der Does, 2002a] consists of
34 items and assesses the effects of dysphoric mood on
cognitions (‘‘cognitive reactivity’’).
Depression severity. The Hamilton Depression
Rating Scale (HAM-D-17) was administered to
patients to assess the severity of depressive symptoms
[Hamilton, 1967].
Cognition. The cognitive test-battery took about
50min to complete.
Word learning test [Saan and Deelman, 1986]. A
list of 15 unrelated neutral words was presented on a
tape. Immediate recall was tested after each of five
consecutive presentations. After the fifth trial, subjects
continued with a nonverbal task. Fifteen minutes later
delayed recall was tested. Immediate recall perfor-
mance was defined as the total of correct words
remembered over the five trials. Delayed recall
performance was defined as the number of correct
words produced at delayed recall.
Verbal fluency. This task is a measure of strategy-
driven retrieval from semantic memory within a fixed
time span [Schmitt et al., 2000]. Participants were
instructed to produce as many correct four letter words
as possible with the same initial letter within 1min.
The starting letters were H, M, R, or L; these were
randomized over the participants. The total number of
correct reported words was registered.
Implicit Association Test. The Implicit Association
Test is a sorting task that assesses implicit associations
on the basis of reaction times [RTs; Egloff and
Schmukle, 2002; Greenwald et al., 1998]. This test is
used extensively in social psychological research to
assess stereotypes [Greenwald and Banaji, 1995].
Participants are asked to sort stimuli representing four
categories by pressing the appropriate key (each
response key was assigned to two categories). If two
categories are strongly related, the sorting task will be
easier (i.e. faster RTs) when the categories share the
same response key than when they share different
response keys. We used an emotional and a neutral
version of this task. Only median latencies for correct
responses were included in the analyses. RTs to
congruent (e.g. self and positive stimuli, insect and
negative stimuli) and incongruent stimuli (e.g. self and
negative stimuli, flowers and negative stimuli) were
calculated.
Dot-probe test. This task measures attentional bias
to emotional stimuli [MacLeod et al., 1986]. Word
pairs (threat words with neutral words and depression-
related words with positive words) were presented on
a computer screen for 500msec, one in the upper part
of the screen and one below. Following the termination
of that display, a dot appeared on the location of either
word. Participants had to indicate the location of the
dot by pressing a key. All word pairs were preceded by a
white fixation cross for 500msec. To control for
possible outliers, only median latencies for correct
responses were included in the analyses. Attentional
bias was calculated by subtracting the RT for positive
(neutral) words from the RT for depressive (threaten-
ing) words.
Facial expression recognition test. The facial
expression recognition task, adapted from Harmer
et al. [2003b], features examples of five basic emo-
tions—happiness, sadness, fear, anger, and disgust
[Ekman and Friesen, 1976]. Emotional expression
intensity was averaged between neutral (0%) and
emotional standard (100%) in 10% steps, providing a
range of emotional intensities. Each emotion intensity
was presented by two examples (one male and one
female face) in random order. Each face was presented
on a computer screen for 500msec and immediately
replaced by a blank screen. Participants made their
response by pressing a labeled key, after that the next
face appeared on the screen. They were instructed to
respond as quickly and accurately as possible. Accuracy
of recognition was calculated over the different
intensity levels in five (20%) blocks. RTs for correct
responses were calculated.
Procedure
Patients. After showing interest in taking part, all
volunteers were given oral and written information
about the study. Informed consent was obtained and
participants who seemed to meet criteria were invited
for the first session. During this session, the Structured
Clinical Interview for DSM-IVAxis I Disorders-IV was
administered to ensure patients no longer fulfilled
criteria for MDD [First et al., 1995]. Participants filled
out all questionnaires and afterwards the cognitive tests
were carried out. The session lasted 2–3 hr. Clinical
background information was checked in medical
records. The study was approved by an independent
medical ethics committee (METIGG, Utrecht).
Controls. The healthy control subjects came in for
one session in which the Structured Clinical Interview
(footnote continued)
because in these two reports, baseline data were calculated on the
basis of the screening session and a post-intervention session.
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for DSM-IV Axis I Disorders-IV was administered to
check the absence of mood disorders and other
exclusion criteria. All questionnaires were filled out
and the cognitive tests were performed during the same
session, which lasted 2–3 hr.
STUDY 2
Inclusion and exclusion criteria, methods, and
procedures were identical to study 1. However, the
DAS was not filled out and the LEIDS was only
completed by patients and therefore not reported here.
Cognition. The cognitive tests took approximately
60min.
Verbal fluency. This test was identical to the
fluency test in study 1.
Stroop Color Word Test. This test measures
focused attention and response inhibition. Names of
colors (red, yellow, blue, and green) printed in black
were presented one by one for a maximum of
1,500msec on a computer screen. Participants were
instructed to read these words as fast as possible
(condition I). Next, colored patches were presented
(condition II). Finally, the names of colors printed in an
incongruent color were presented and participants
were instructed to name the color of the ink (condition
III). Median RTs were recorded. Interference was
defined as the extra time needed for condition III
relative to the average of conditions I and II.
Emotional Stroop Test. This test was used to
assess attentional bias for emotional material. The
stimuli were positive, neutral, or depression-related
words. Words printed in color were presented
consecutively on a computer screen. Participants were
asked to name the colors as quickly as possible. The
order of the word categories was randomized over the
patients. The order of the words within each category
was randomized.
Left/right choice RT. This test assesses motor
speed and response inhibition as a function of task
difficulty. The word ‘‘left’’ or ‘‘right’’ was presented in
randomized order (1,000msec) either at the left or the
right side of the screen. Participants were instructed to
respond to the meaning of the word but to ignore its
location, as fast as possible. Correct responses and RTs
were registered.
Tower of London. The Tower of London [TOL;
Owen et al., 1995] is a planning task consisting of three
colored balls (red, yellow, and blue) placed on three
sticks in various arrangements. Two arrangements were
presented on the upper and lower half of the screen.
The patient was instructed to indicate the minimal
number of moves necessary to change the first
arrangement into the second (two to five moves).
Correct responses and RTs were registered.
Abstract Patterns Recognition Task. The Ab-
stract Patterns Recognition Task [APRT; Rubinsztein
et al., 2001] measures (speed of) recognition of
nonverbal abstract information from short- and long-
term memory. Sixteen abstract patterns were presented
consecutively for 3,000msec, with 500msec intervals.
Participants were instructed to memorize the patterns.
After three presentations of the complete series, two
patterns were presented simultaneously; one that had
been learned and a new pattern. Participants had to
indicate as fast as possible which one had been
presented previously. The recognition procedure was
repeated after 35min, during which verbal tasks were
administered. Sensitivity measures (A0) were calculated
for the proportion of correctly recognized patterns,
corrected for response tendency by the formula:
A05 11/4 [fr/cr1(1cr)/(1fr)], in which fr5 the
proportion of falsely recognized patterns and cr5
proportion of correctly recognized patterns, following
signal detection theory [Pollack and Norman, 1964].
STATISTICAL ANALYSIS
Data were first screened for missing values, outliers,
normal distributions, and homogeneity of variance.
Differences between patients and controls were
analyzed with GLM analysis of variance with Group
as a fixed factor and BDI-II total score as a covariate.
As matching for Level of education was unsuccessful in
study 1, this variable was also entered as a covariate in
the analyses of the cognitive measures from study 1.
Data from the Facial Emotion Recognition task were
analyzed with GLM repeated measures analysis with
Emotion (happiness, sadness, fear, anger, and disgust)
as a within-subjects factor and Group (controls versus
remitted depressed patients) as a between-subjects
factor and BDI-II and Level of education as covariates.
The TOL was also analyzed using GLM repeated
measures with Steps (2, 3, 4, 5) as a within-subjects
factor and Group as a between-subjects factor and
BDI-II as a covariate. Data are reported as mean7-
standard deviations. All tests were corrected for multi-
ple testing using Bonferroni corrections.
RESULTS
STUDY 1
Data screening. On the Facial Expression Recog-
nition task, RT data were missing for one emotion in
two control participants, one of whom did not
recognize any sad faces correctly, the other did not
recognize any angry faces correctly. On the Word
Learning Test, data were missing for one control
subject for the immediate recall, due to technical
problems. One control subject was an outlier on the
Word Learning Test as well as the Implicit Association
Test Neutral. Another control was an outlier on the
Dot-probe test. Analyses were conducted with and
without statistical outliers, however results were
similar.
Participants. Twenty healthy controls and
19 remitted depressed subjects were included in the
study. Participants were well matched on age and
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gender, however the control group had a higher level of
education compared to the patient group (w25 10.6,
P5.005). Current comorbid diagnoses in the remitted
depressed group were social phobia (n5 1), specific
phobia (n5 2), chronic posttraumatic stress disorder
(n5 1), and dysthymia (n5 4). Tables 1 and 2 show
clinical and demographical characteristics of both
patients and controls of studies 1 and 2.
Self-report measures. Recovered depressed
patients scored higher on the BDI-II (t(19.6)55.5,
Po.001) compared to controls. Patients also scored
higher on the DAS (t(37)53.7, P5.001) and on
some subscales of the LEIDS compared to the control
group: Harm Avoidance (t(37)56.6, Po.001),
Rumination (t(37)59.6, Po.001), Hopelessness
(t(37)52.2, P5.037), and on the Total score
(t(37)54.2, Po.001). Controls scored higher on
Acceptance/Coping (t(37)5 2.3, P5.026) and Aggres-
sion (t(37)5 2.2, P5.031). When controlled for
residual depressive symptoms, only the differences on
the LEIDS total score (F(1,36)5 7.3, P5.010), Rumi-
nation (F(1,36)5 39.9, Po.000) and Harm Avoidance
(F(1,36)5 16.5, Po.001) remained significant.
Cognition. See Table 3a for the cognitive tests of
study 1.
Facial Expression Recognition Test. Only a sig-
nificant effect of Emotion (F(3.9,137.6)5 10.3,
Po.001) was found on the overall accuracy data,
indicating that participants were better at recognizing
certain emotions compared to others (see Fig. 1). The
main effect of Group was not significant (F(1,35)5 1.5,
P5.233). Separate analyses per Emotion revealed a
significant effect of Group (F(1,35)5 5.5, P5.024) for
the recognition of fear, indicating that remitted
depressed patients were better at recognizing facial
expressions of fear compared to controls. Univariate
analyses on fear accuracy per intensity level (in five
20% blocks) showed that the effect of Group was
significant or borderline significant for all levels, except
for the 30–40% intensity level: 10–20% F(1,35)5 4.2,
P5.049; 30–40% F(1,35)5 0.1, P5.788; 50–60%
F(1,35)5 4.1, P5.049; 70–80% F(1,35)5 7.2,
P5.011; 90–100% F(1,35)5 4.1, P5.051 (see Fig. 2).
No significant main and interaction effects were found
for the other emotions.
Regarding the RT data, a significant effect of
Emotion was found (F(2.7,88.0)5 4.1, P5.011). The
main effect of Group was not significant (F(1,33)5 0.0,
P5.834). When analyzed per emotion, no significant
effects of Group or GroupEmotion were found.
No other significant differences between the groups
on cognitive performance were found in study 1.
STUDY 2
Data screening. One patient missed all four- and
five-step problems of the TOL. One control partici-
pant missed all five-step problems of the TOL. Data
for another control participant are missing for all
positive words on the Emotional Stroop task. Cases
with missing data were omitted separately by analysis.
Outliers were found on the APRT, Stroop CWT,
and Emotional Stroop test. Analyses were conducted
with and without statistical outliers, however results
were similar. The Verbal Fluency data were success-
fully log 10 transformed because of a non-normal
distribution.
Participants. Twenty-one controls and 20
remitted depressed patients were included in this study.
The control group did not differ from the patient
group in terms of gender, age, and education level. Past
comorbid diagnoses in the remitted depressed patient
group were panic disorder (n5 3, of whom one in
partial remission), social phobia (n5 1), and anorexia
nervosa (n5 1).
Self-report. The remitted group had higher BDI-
II scores compared to the control group
(F(1,39)5 9.19, P5.004).
Cognition. See Table 3b for the cognitive tests of
study 2.
APRT. A significant effect of Group was found for
the recognition from long-term memory (A0):
TABLE 1. Characteristics of study 1 and study 2, values
presented as means (SD)
Study 1
Controls
(n5 20)
Patients
(n5 19)
t df P
Age (SD) 47.7 (14.1) 44.2 (13.0) 0.8 37 .426
BDI-II 1.4 (1.7) 11.7 (8.0) 5.5 19.6 .000
LEIDS total score 24.7 (12.6) 40.0 (9.7) 4.2 37 .000
DAS 58.8 (15.9) 80.2 (19.8) 3.7 37 .001
w2 df P
M/F 1/19 2/17 0.4 1 .517
Education level 10.6 2 .005
Low n5 2 n5 7
Medium n5 8 n5 11
High n5 10 n5 1
Study 2
Controls
(n5 21)
Patients
(n5 20)
t df P
Age 44.1 (10.2) 48.7 (7.9) 1.6 39 .114
BDI-II 5.2 (5.3) 12.9 (10.1) 3.0 28.4 .006
w2 df P
M/F 9/12 11/9 0.6 1 .437
Education level 0.8 2 .665
Low n5 5 n5 3
Medium n5 6 n5 8
High n5 10 n5 9
BDI-II, Beck Depression Inventory, 2nd edition; LEIDS, Leiden
Index for Depression Sensitivity; DAS, Dysfunctional Attitudes Scale
Po.010.
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TABLE 2. Clinical characteristics of both patient groups (mean7SD)
Study 1 (n5 19) Study 2 (n5 20)
HAM-D17 7.7 (3.6) [range 1–13] 5.6 (3.8) [range 0–13]
Type of medication
SSRI n5 13 n5 13a
SSNRI n5 6 (150–375mg) n5 7 (75–225mg)
Type of remissionb
Partial remission n5 8 n5 13
Full remission n5 11 n5 7
Duration of remission
(months)7SD
13.1722.3 [range 1–102]c 5.975.6 [range 1–24]
Number of episodes7SD 4.974.1 [range 1–15] 4.874.4 [range 1–16]
Single/recurrent episode(s) 2/17 4/16
Diagnosis, subtyped
MDD, melancholic n5 16 n5 11
MDD, atypical n5 1 n5 6
MDD, seasonal pattern — n5 2
Not melancholic, atypical, or catatonic n5 2 n5 1
HAM-D, Hamilton Rating Scale for Depression; SSRI, Selective Serotonin Reuptake Inhibitor; SSNRI, Selective Serotonin and Noradrenalin
Reuptake Inhibitor.
aTwo SSRI treatment free for 1 month.
bAccording to the criteria of Frank et al. [1991].
cThis wide range is caused by one patient who had been recovered for over 8 years; without that patient the range is [1, 21].
dSubtype of most recent depressive episode.
TABLE 3a. Cognitive tests of study 1, presented as means (SD)
Controls (n5 20) Patients (n5 19) F df P
Verbal memory (WLT)
Immediate recall # correct 52.0 (9.0) 49.6 (11.0) 0.3 1,34 .581
Delayed recall # correct 11.1 (2.2) 10.8 (2.7) 1.3 1,35 .260
Verbal fluency
# correct 12.4 (3.6) 9.9 (3.5) 0.03 1,35 .868
IAT Neutrala
RTcongruent (msec) 685.7 (107.8) 663.3 (126.4) 2.4 1,35 .134
RT incongruent (msec) 1139.8 (271.2) 1049.0 (273.6) 1.1 1.35 .294
IAT Emotional
RTcongruent (msec) 828.6 (209.2) 897.3 (304.2) 0.1 1,35 .717
RT incongruent (msec) 742.4 (111.8) 847.4 (245.3) 0.1 1,35 .816
Dot-probe
AB depressive—positive (msec) 2.3 (20.5) 1.3 (22.9) 0.0 1,35 .904
AB anxious—neutral (msec) 1.4 (18.1) 6.0 (16.5) 0.4 1,35 .524
FERT
Accuracy 1.5 1,35 .233
Anger 1.6 (0.8) 1.7 (0.6) 0.5 1,35 .505
Fear 1.8 (0.6) 2.0 (0.5) 5.5 1,35 .024
Sadness 1.3 (0.8) 1.4 (0.7) 1.3 1,35 .268
Happiness 2.7 (0.4) 2.8 (0.3) 0.2 1,35 .669
Disgust 2.5 (0.5) 2.5 (0.6) 0.0 1,35 .836
Speed (msec) 0.0 1,33 .834
Anger 1061.1 (344.2) 1205.2 (305.4) 0.1 1,34 .783
Fear 1123.9 (525.6) 1212.1 (464.9) 0.3 1,35 .578
Sadness 1459.6 (495.5) 1514.2 (981.0) 0.3 1,34 .568
Happiness 805.1 (190.5) 870.9 (233.6) 0.0 1,35 .999
Disgust 907.8 (263.1) 1114.9 (691.3) 0.4 1,35 .542
AB, attentional bias; FERT, Facial Expression Recognition Test; IAT, Implicit Attitudes Test; RT, reaction time; WLT, Word Learning Test.
Po.05, F values present the main effect of Group.
aAnalyses without one outlier are presented. All analyses were performed with Bonferroni corrections.
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F(1,38)5 5.0, P5.030. Patients appeared to perform
worse than controls at recognition of abstract visual
information from long-term memory.
DISCUSSION
The current results indicate that medicated remitted
depressed patients show an increased recognition of
facial expressions of fear compared to healthy controls,
even after statistical correction for differences in
depressive symptoms. Also, patients scored higher on
a self-report measure of cognitive reactivity and
performed worse than controls at a task measuring
recognition of abstract information from long-term
memory. No other residual cognitive impairments were
found on a wide range of tests, despite the fact that the
patients still suffered from residual depressive symp-
toms and were relatively chronic. The BDI-II scores of
patients were higher than those of healthy controls,
although both groups’ scores were within the normal
range [Van der Does, 2002b]. These findings support
the view that most cognitive deficits associated with
depression are associated with clinical status, rather
than a persisting vulnerability factor [Weiland-Fiedler
et al., 2004]. Some deficits may be more persistent,
however, and the higher cognitive reactivity scores
suggest that the deficits may have become ‘‘latent’’.
A number of studies have shown that cognitive
deficits may not be apparent when they are only
assessed at ‘‘resting’’ state [Lau et al., 2004]. This
implies that negative information processing biases
may be rather easily activated by dysphoric mood
states—either naturally occurring or induced in the
laboratory. This process is called cognitive reactivity.
Cognitive reactivity is an important vulnerability factor
that is linked to depressive relapse [Segal et al., 2006].
The finding of this study that the difference between
remitted depressed patients and controls in DAS scores
became nonsignificant after controlling for residual
symptoms is in line with Miranda et al. [1990], who
have already shown that dysfunctional attitudes are
mood-state dependent for subjects with a history of
depression. The group differences on the LEIDS,
which aim to measure reactivity of cognitions,
remained significant after correction. The current
findings therefore suggest that some of the other
cognitive deficits might also be more easily triggered in
remitted depressed patients than in never-depressed
individuals. In line with our findings, Gemar et al.
[2001] did not find any baseline differences when they
studied implicit attitudes in formerly depressed and
never depressed subjects. Only after a sad mood
induction, a shift was found toward a negative
evaluative bias in the formerly depressed group, again
supporting the suggestion that cognitive impairments
may become latently present following clinical recovery.
Interestingly, the finding that remitted depressed
patients were better in recognizing fear indicates that
facial expression recognition may be a scar and a
persisting vulnerability factor for relapse to depression.
Bhagwagar et al. [2004] also found increased recogni-
tion of fear in recovered depressed subjects relative
to controls, however administration of a single dose
of citalopram normalized this increased fear recogni-
tion. In contrast, our patients were already medicated
for more than 4 weeks before entering the study.
Bouhuys et al. [1999] found that increased perception
of negative emotions is related to relapse, although the
recognition of negative emotions decreased from
the acute to the remitted phase. The conceptualization
of fear recognition as a vulnerability marker was
further supported in a study by Masurier et al.
[2007], who found faster recognition of facial
Figure 1. Facial emotion recognition for controls and remitted
depressed patients (mean7SEM).
Figure 2. Fear accuracy over the different intensity levels
(mean7SEM).
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expressions of fear in female first-degree relatives
of depressed patients compared to controls without
a family history of depression. Biases in the process-
ing of emotional information may thus be a stable
trait characteristic, even occurring before the
onset of a first depressive episode [Leppa¨nen, 2006;
review].
Finally, the finding that the remitted depressed patients
performed worse on a test measuring recognition from
long-term visual memory is in line with previous studies,
which have shown persisting impairments in memory
processes in euthymic patients [Marcos et al., 1994].
In the current studies, remitted depressed patients
were not impaired on tests measuring attentional bias.
Studies in recovered depressed subjects mainly used the
Stroop Color Word task to measure attentional bias.
Both Paradiso et al. [1997] and Trichard et al. [1995]
found persisting impairments in Stroop performance in
recovered depressed patients. Attentional bias is thought to
be not only a symptom of depression, but also to be
important in the development and maintenance of
depressive disorders [Williams et al., 1996]. Our results
do not support this position, because no impairments were
found on neutral and emotional Stroop interference as well
as on attentional bias measured with the Dot-probe test.
However, the literature on attentional bias in depression is
contradictory, which may be explained by the differences in
stimulus presentation times [Mathews et al., 1996; Mogg
et al., 1995]. Studies using the Dot-probe test have found
attentional biases in depression using relatively long
stimulus presentations [1 sec or more; Mogg et al., 1995].
When stimuli are presented for shorter durations, results
are mixed [Bradley et al., 1997; Mathews et al., 1996]. Our
stimulus presentation time of 500msec was probably not
optimal to detect group differences.
One factor that might limit interpretation of the data
is that patients were treated with serotonergic anti-
depressants when participating in the study. Seroto-
nergic antidepressants may have some sedative side
effects, but these tend to wear off in the first 2 weeks of
treatment [Amado-Boccara et al., 1995] and the effects
on memory and psychomotor performance are of low
TABLE 3b. Cognitive tests of study 2, presented as means (SD)
Controls (n5 21) Patients (n5 20) F df P
Verbal fluency
# correct 10.4 (3.9) 12.1 (5.1) 0.1 1,38 .720
Stroop CWT
Condition I (msec) 567.0 (76.9) 552.5 (72.8) 0.2 1,38 .664
Condition II (msec) 487.5 (62.5) 490.2 (56.0) 0.1 1,38 .784
Condition III (msec) 775.7 (156.4) 792.0 (109.8) 0.0 1,38 .906
Interference (%) 47.3 (23.8) 52.3 (16.7) 0.1 1,38 .774
Emotional Stroop Task
Negative words (msec) 712.3 (88.2) 749.6 (115.0) 0.0 1,38 .895
Neutral words (ms) 693.7 (91.4) 722.5 (74.3) 0.1 1,38 .741
Positive words (msec) 702.1 (124.1) 705.3 (83.4) 0.1 1,37 .729
Interference negative (%) 3.1 (9.2) 3.7 (9.9) 0.1 1,38 .780
Interference positive (%) 1.7 (10.7) 2.3 (6.7) 1.1 1,37 .295
Left/right task
Congruent (msec) 634.9 (94.2) 678.4 (58.9) 0.9 1,38 .353
Incongruent (msec) 652.0 (97.7) 700.4 (54.6) 2.0 1,38 .168
Tower of London
% correct 0.3 1,36 .584
2 steps 88.1 (17.5) 84.5 (16.7)
3 steps 85.2 (19.4) 78.5 (11.8)
4 steps 72.9 (15.5) 75.8 (21.2)
5 steps 65.0 (24.0) 54.7 (29.9)
RT (msec) 0.1 1,36 .812
2 steps 5337.3 (1190.4) 6733.6 (2001.4)
3 steps 7359.3 (2424.0) 8101.8 (3388.0)
4 steps 10869.1 (3101.7) 11902.9 (4482.1)
5 steps 19407.5 (7191.4) 17908.7 (8352.7)
APRT
A0 STM (%) 83.0 (9.7) 78.3 (11.7) 1.5 1,38 .226
A0 LTM (%) 80.5 (9.9) 74.9 (14.2) 5.0 1,38 .030
RT STM (msec) 2164.2 (805.6) 2308.0 (802.9) 0.8 1,38 .380
RT LTM (msec) 1976.4 (715.5) 2107.9 (597.3) 0.1 1,38 .808
CWT, Color Word Test; APRT, Abstract Visual Patterns Task.
F values represent the main effect of Group. All analyses were performed with Bonferroni corrections.
Po.05.
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intensity [Gorenstein et al., 2006; Thompson, 1991]. In
contrast, SSRIs have been found to positively affect
neutral and emotional information processing acutely
and after 7–14 days [Bhagwagar et al., 2004; Harmer
et al., 2002, 2003a, 2004, 2006]. However, unmedicated
recovered depressed patients also did not show any
differences in neutral information processing compared
to healthy controls [Booij et al., 2006], although these
groups did differ on cognitive reactivity [Merens et al.,
2005]. The latter studies used a considerably younger
and less chronic sample, however. How chronic SSRI
use affects emotional processing is still unclear, so it
may be possible that some cognitive impairments were
remediated by SSRI treatment.
It also has to be considered that the lack of
differences between groups in this study may have
been caused by insufficient statistical power. Sample
sizes in both studies are relatively small and replication
in larger samples is warranted. The fact that both
patient groups were not completely asymptomatic,
only strengthens our conclusion that remitted
depressed patients do not suffer from many cognitive
impairments. Also, remission status (partial versus full)
did not affect the facial expression recognition data.
Future research may investigate the influence of
clinical variables (chronicity, age of onset, treatment
modality etc.) on cognitive performance of remitted
depressed patients, to clarify possible mediating factors
leading to cognitive impairment in depression. Finally,
as cognitive function was not assessed during the acute
phase of the depressive episode, it cannot be ruled out
that we selected groups of remitted depressed patients
who showed little cognitive impairments even in a
depressed state. However, this seems very unlikely
because cognitive impairments in depression are
common [Austin et al., 2001; Elliott, 1998] and both
patients groups were relatively chronic.
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